Confluent initiated with Outperform on cloud growth at William Blair 07:20 CFLT
Is it time to go for trade #3?
Raymond James starts reopening beneficiary Vivid Seats with an Outperform 06:33 SEAT Raymond James analyst Andrew Marok initiated coverage of Vivid Seats with an Outperform rating and $17 price target, calling it a "major beneficiary of pandemic reopenings." Fundamental positives to the Vivid story include a strong rebound in U.S. live events from the pandemic, a solid long-term market backdrop, opportunities to leverage marketing spend to drive buyers onto the platform, the company's differentiated SkyBox software platform for large sellers and his expectations for double digit long-term revenue growth and greater than 30% EBITDA margins, Marok said.
Is it time to go for trade #3?
Raymond James starts reopening beneficiary Vivid Seats with an Outperform 06:33 SEAT Raymond James analyst Andrew Marok initiated coverage of Vivid Seats with an Outperform rating and $17 price target, calling it a "major beneficiary of pandemic reopenings." Fundamental positives to the Vivid story include a strong rebound in U.S. live events from the pandemic, a solid long-term market backdrop, opportunities to leverage marketing spend to drive buyers onto the platform, the company's differentiated SkyBox software platform for large sellers and his expectations for double digit long-term revenue growth and greater than 30% EBITDA margins, Marok said.